Milestone Pharmaceuticals (NASDAQ:MIST) Now Covered by HC Wainwright
Equities researchers at HC Wainwright assumed coverage on shares of Milestone Pharmaceuticals (NASDAQ:MIST – Get Free Report) in a research note issued to investors on Thursday, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $5.00 price target on the stock. HC Wainwright’s price target would suggest a potential upside of 189.02% from […]
Equities researchers at HC Wainwright assumed coverage on shares of Milestone Pharmaceuticals (NASDAQ:MIST – Get Free Report) in a research note issued to investors on Thursday, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $5.00 price target on the stock. HC Wainwright’s price target would suggest a potential upside of 189.02% from […]
